272 related articles for article (PubMed ID: 15647328)
1. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis.
Machida T; Heerdt PM; Reid AC; Schäfer U; Silver RB; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2005 May; 313(2):570-7. PubMed ID: 15647328
[TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and postsynaptic purinergic P2 receptors.
Schaefer U; Machida T; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2007 Sep; 322(3):1269-77. PubMed ID: 17565006
[TBL] [Abstract][Full Text] [Related]
3. Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia.
Sesti C; Koyama M; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2003 Jul; 306(1):238-44. PubMed ID: 12676879
[TBL] [Abstract][Full Text] [Related]
4. The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons.
Corti F; Olson KE; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2011 May; 337(2):524-32. PubMed ID: 21325440
[TBL] [Abstract][Full Text] [Related]
5. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
6. EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release.
Sesti C; Broekman MJ; Drosopoulos JH; Islam N; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2002 Feb; 300(2):605-11. PubMed ID: 11805223
[TBL] [Abstract][Full Text] [Related]
7. CD39 modulates IL-1 release from activated endothelial cells.
Imai M; Goepfert C; Kaczmarek E; Robson SC
Biochem Biophys Res Commun; 2000 Apr; 270(1):272-8. PubMed ID: 10733939
[TBL] [Abstract][Full Text] [Related]
8. E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role.
Aldi S; Marino A; Tomita K; Corti F; Anand R; Olson KE; Marcus AJ; Levi R
FASEB J; 2015 Jan; 29(1):61-9. PubMed ID: 25318477
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
10. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
Alvarado-Castillo C; Harden TK; Boyer JL
Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norepinephrine release?
Seyedi N; Maruyama R; Levi R
J Pharmacol Exp Ther; 1999 Aug; 290(2):656-63. PubMed ID: 10411575
[TBL] [Abstract][Full Text] [Related]
12. Soluble apyrases release adp during ATP hydrolysis.
Chen W; Guidotti G
Biochem Biophys Res Commun; 2001 Mar; 282(1):90-5. PubMed ID: 11263976
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts.
Hatta E; Maruyama R; Marshall SJ; Imamura M; Levi R
J Pharmacol Exp Ther; 1999 Mar; 288(3):919-27. PubMed ID: 10027827
[TBL] [Abstract][Full Text] [Related]
14. The ratio of ADP- to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease.
El-Omar MM; Islam N; Broekman MJ; Drosopoulos JH; Roa DC; Lorin JD; Sedlis SP; Olson KE; Pulte ED; Marcus AJ
Thromb Res; 2005; 116(3):199-206. PubMed ID: 15935828
[TBL] [Abstract][Full Text] [Related]
15. Expression of NTPDase1 and caveolins in human cardiovascular disease.
Kittel A; Kiss AL; Müllner N; Matkó I; Sperlágh B
Histochem Cell Biol; 2005 Jul; 124(1):51-9. PubMed ID: 16028070
[TBL] [Abstract][Full Text] [Related]
16. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain.
Braun N; Sévigny J; Robson SC; Enjyoji K; Guckelberger O; Hammer K; Di Virgilio F; Zimmermann H
Eur J Neurosci; 2000 Dec; 12(12):4357-66. PubMed ID: 11122346
[TBL] [Abstract][Full Text] [Related]
17. Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings.
Silver RB; Poonwasi KS; Seyedi N; Wilson SJ; Lovenberg TW; Levi R
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):501-6. PubMed ID: 11752397
[TBL] [Abstract][Full Text] [Related]
18. Modulation of firing activity by ATP in dopamine neurons of the rat substantia nigra pars compacta.
Choi YM; Jang JY; Jang M; Kim SH; Kang YK; Cho H; Chung S; Park MK
Neuroscience; 2009 May; 160(3):587-95. PubMed ID: 19272429
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor-stimulated neuronal differentiation induces changes in P2 receptor expression and nucleotide-stimulated catecholamine release.
Arthur DB; Taupenot L; Insel PA
J Neurochem; 2007 Mar; 100(5):1257-64. PubMed ID: 17241236
[TBL] [Abstract][Full Text] [Related]
20. Catecholamines in myocardial ischemia. Systemic and cardiac release.
Schömig A
Circulation; 1990 Sep; 82(3 Suppl):II13-22. PubMed ID: 2203558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]